188 related articles for article (PubMed ID: 18382139)
1. Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness.
Eko FO; Talin BA; Lubitz W
Hum Vaccin; 2008; 4(3):176-83. PubMed ID: 18382139
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
Badamchi-Zadeh A; McKay PF; Holland MJ; Paes W; Brzozowski A; Lacey C; Follmann F; Tregoning JS; Shattock RJ
PLoS One; 2015; 10(10):e0141209. PubMed ID: 26501198
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection.
Whittum-Hudson JA; An LL; Saltzman WM; Prendergast RA; MacDonald AB
Nat Med; 1996 Oct; 2(10):1116-21. PubMed ID: 8837610
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques.
Olivares-Zavaleta N; Whitmire WM; Kari L; Sturdevant GL; Caldwell HD
J Immunol; 2014 May; 192(10):4648-54. PubMed ID: 24711617
[TBL] [Abstract][Full Text] [Related]
5. [New vaccine against trachoma].
Vérin P; Liotet S; Catalan F; Mortemousque B; Hasseini KC
Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1996; 73():63-71. PubMed ID: 9889570
[TBL] [Abstract][Full Text] [Related]
6. Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers.
Inic-Kanada A; Stojanovic M; Schlacher S; Stein E; Belij-Rammerstorfer S; Marinkovic E; Lukic I; Montanaro J; Schuerer N; Bintner N; Kovacevic-Jovanovic V; Krnjaja O; Mayr UB; Lubitz W; Barisani-Asenbauer T
PLoS One; 2015; 10(12):e0144380. PubMed ID: 26656797
[TBL] [Abstract][Full Text] [Related]
7. Towards a Chlamydia trachomatis vaccine: how close are we?
Cochrane M; Armitage CW; O'Meara CP; Beagley KW
Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665
[TBL] [Abstract][Full Text] [Related]
8. Overview of Chlamydia trachomatis infection and the requirements for a vaccine.
Schachter J
Rev Infect Dis; 1985; 7(6):713-6. PubMed ID: 3840910
[TBL] [Abstract][Full Text] [Related]
9. Towards a safe and effective chlamydial vaccine: lessons from the eye.
Mabey DC; Hu V; Bailey RL; Burton MJ; Holland MJ
Vaccine; 2014 Mar; 32(14):1572-8. PubMed ID: 24606636
[TBL] [Abstract][Full Text] [Related]
10. Antibody signature of spontaneous clearance of Chlamydia trachomatis ocular infection and partial resistance against re-challenge in a nonhuman primate trachoma model.
Kari L; Bakios LE; Goheen MM; Bess LN; Watkins HS; Southern TR; Song L; Whitmire WM; Olivares-Zavaleta N; Caldwell HD
PLoS Negl Trop Dis; 2013; 7(5):e2248. PubMed ID: 23738030
[TBL] [Abstract][Full Text] [Related]
11. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
[TBL] [Abstract][Full Text] [Related]
12. Chlamydial genomics and vaccine antigen discovery.
Stephens RS
J Infect Dis; 2000 Jun; 181 Suppl 3():S521-3. PubMed ID: 10839752
[TBL] [Abstract][Full Text] [Related]
13. Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?
Faal N; Bailey RL; Jeffries D; Joof H; Sarr I; Laye M; Mabey DC; Holland MJ
PLoS Med; 2006 Aug; 3(8):e266. PubMed ID: 16881731
[TBL] [Abstract][Full Text] [Related]
14. Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis.
Frick KD; Colchero MA; Dean D
Vaccine; 2004 Jan; 22(5-6):689-96. PubMed ID: 14741161
[TBL] [Abstract][Full Text] [Related]
15. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
[TBL] [Abstract][Full Text] [Related]
16. Immunofibrogenic Gene Expression Patterns in Tanzanian Children with Ocular
Ramadhani AM; Derrick T; Macleod D; Massae P; Mtuy T; Jeffries D; Roberts CH; Bailey RL; Mabey DCW; Holland MJ; Burton MJ
Front Cell Infect Microbiol; 2017; 7():406. PubMed ID: 28966918
[TBL] [Abstract][Full Text] [Related]
17. Trachoma: transmission, infection, and control.
Gambhir M; Basáñez MG; Turner F; Kumaresan J; Grassly NC
Lancet Infect Dis; 2007 Jun; 7(6):420-7. PubMed ID: 17521595
[TBL] [Abstract][Full Text] [Related]
18. Review: Targeting trachoma: Strategies to reduce the leading infectious cause of blindness.
Baneke A
Travel Med Infect Dis; 2012 Mar; 10(2):92-6. PubMed ID: 22326056
[TBL] [Abstract][Full Text] [Related]
19.
Chavda VP; Pandya A; Kypreos E; Patravale V; Apostolopoulos V
Expert Rev Vaccines; 2022 Jun; 21(6):771-781. PubMed ID: 35470769
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia vaccines: strategies and status.
Igietseme JU; Black CM; Caldwell HD
BioDrugs; 2002; 16(1):19-35. PubMed ID: 11908999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
